EverPoint Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$14.7M Buy
262,000
+78,600
+43% +$4.6M 0.27% 101
2016
Q3
$10.9M Buy
+183,400
New +$10.7M 0.2% 134
2015
Q2
Sell
-262,000
Closed -$14.4M 541
2015
Q1
$14.4M Buy
262,000
+73,360
+39% +$4.15M 0.27% 118
2014
Q4
$10.2M Sell
188,640
-262,000
-58% -$14.6M 0.23% 146
2014
Q3
$25.5M Buy
450,640
+188,640
+72% +$10.6M 0.58% 39
2014
Q2
$14.5M Buy
+262,000
New +$14.3M 0.3% 91

Other funds holding MRK

EverPoint Asset Management's MRK Position: Q4 2016 in Review

EverPoint Asset Management increased its Merck (MRK) stake by 43% in Q4 2016, buying an estimated $4.6M and bringing the position to 262,000 shares worth $14.7M. The position accounts for 0.27% of the portfolio, ranked #101.

EverPoint Asset Management first reported a position in MRK in Q2 2014 and has held it in 6 quarters since. The position peaked at $25.5M in Q3 2014. 1,913 funds tracked by Wall St. Rank hold MRK as of Q4 2016.

  • EverPoint Asset Management held 262,000 shares of Merck worth $14.7M as of Q4 2016.
  • EverPoint Asset Management bought 78,600 Merck shares in Q4 2016, an estimated $4.6M.
  • Merck made up 0.27% of EverPoint Asset Management's portfolio in Q4 2016, its #101 holding.
  • EverPoint Asset Management first reported a position in Merck in Q2 2014 and has held it in 6 quarters since.
  • EverPoint Asset Management's Merck position peaked at $25.5M in Q3 2014.
  • 1,913 funds tracked by Wall St. Rank held Merck as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.